COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab. - Dimai S; Semmler L; Prabhu A; Stachelscheid H; Huettemeister J; Klaucke SC; Lacour P; Blaschke F; Kruse J; Parwani A; Boldt LH; Bullinger L; et al. (PloS one, 2021)